Skip to content
CG

Cresanto Global

531207 BSE
Price unavailable
View as Markdown
MCP
Close 21 Sep 2026 ₹5.37 +1.54 +40.2% since 25 Nov 2025
Start ₹3.83

Key Fundamentals

MicrocapPharmaceuticals & BiotechnologyHealthcare

Price-based figures · EPS basis: Standalone · TTM

ROCE
—
Debt to Equity
Not meaningful: shareholders’ equity is negative
EPS (TTM)
−₹0.93
Book Value
−₹7.08
Market Cap
—
P/E (TTM)
—
P/B
—
ROE
Not meaningful: shareholders’ equity is negative
Dividend Yield
0.00%
EBITDA
−₹30.00 L
52W High
—
52W Low
—

Key Insights

No strengths listed

Weaknesses

2
  • Company has low interest coverage ratio.
  • Promoter holding is low: 32.3%

Technical Indicators

Technical signals: verdict and indicator counts
GroupSignalBearishNeutralBullish
OverallStrong Bullish5113
OscillatorsStrong Bearish513
Moving AveragesStrong Bullish0010

Key readings

RSI (14)
98.61
Bearish
MACD (12,26,9)
0.56
Bullish
SMA (50)
3.40
Bullish
SMA (200)
2.19
Bullish

As of , the latest day with price data, so these readings are not current.

Growth Rate

From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Jun 2026 against Jun 2025.

Revenue

Revenue growth by window
10YZero base
5YZero base
3YZero base
1YZero base
TTMZero base

Net profit

Net profit growth by window
10YLoss widened by ₹0.39 Cr
5YLoss widened by ₹0.36 Cr
3YLoss widened by ₹0.26 Cr
1YLoss widened by ₹0.25 Cr
TTMLoss widened by ₹0.11 Cr

Operating cash flow

Operating cash flow growth by window
10YTurned negative
5YTurned negative
3YOutflow widened by ₹0.11 Cr
1YOutflow narrowed by ₹0.20 Cr
TTM—

TTM: Reported once a year, so there is no trailing-twelve-month figure.

Operating margin· change in pp

Operating margin growth by window
10YNo sales
5YNo sales
3YNo sales
1YNo sales
TTMNo sales

Revenue by year

Revenue by year, ₹ crore
Mar 2017₹0.00 Cr
Mar 2018₹0.00 Cr
Mar 2019₹0.00 Cr
Mar 2020₹0.00 Cr
Mar 2021₹0.00 Cr
Mar 2022₹0.00 Cr
Mar 2023₹0.00 Cr
Mar 2024₹0.00 Cr
Mar 2025₹0.00 Cr
Mar 2026₹0.05 Cr

Net profit by year

Net profit by year, ₹ crore
Mar 2017−₹0.05 Cr
Mar 2018−₹0.06 Cr
Mar 2019−₹0.05 Cr
Mar 2020−₹0.06 Cr
Mar 2021−₹0.07 Cr
Mar 2022−₹0.08 Cr
Mar 2023−₹0.17 Cr
Mar 2024−₹0.10 Cr
Mar 2025−₹0.18 Cr
Mar 2026−₹0.43 Cr

Quarterly Results

₹ Cr
531207 quarterly results, ₹ crore
Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
0
0
0
0
0
0
0
0
0
0.05
0
0
0
Expenses
0.01
0.02
0.02
0.05
0.02
0.02
0.26
0.34
0.09
0.06
0.11
0.08
0.06
Operating Profit
−0.01
−0.02
−0.02
−0.05
−0.02
−0.02
−0.26
−0.34
−0.09
−0.01
−0.11
−0.08
−0.06
OPM %
—
—
—
—
—
—
—
—
—
−20%
—
—
—
Other Income
0
0
0
0
0
0
0.01
0.52
0
0
0.02
0
0
Interest
0
0
0
0
0
0
0
0.11
0
0
0
0.16
0
Depreciation
0
0
0
0
0
0
0
0
0
0
0
0
0
PBT
−0.01
−0.02
−0.02
−0.05
−0.02
−0.02
−0.25
0.07
−0.09
−0.01
−0.09
−0.24
−0.06
Tax %
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Net Profit
−0.02
−0.02
−0.02
−0.05
−0.02
−0.02
−0.25
0.07
−0.09
−0.01
−0.09
−0.24
−0.06
EPS (₹)
−0.05
−0.05
−0.05
−0.12
−0.05
−0.05
−0.59
0.16
−0.21
−0.02
−0.21
−0.56
−0.14

Profit & Loss

₹ Cr
531207 profit and loss, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
0
0
0
0
0
0
0
0
0
0
0
0.05
0.05
Expenses
0.04
0.03
0.03
0.03
0.03
0.06
0.07
0.08
0.19
0.1
0.6
0.34
0.31
Operating Profit
−0.04
−0.03
−0.03
−0.03
−0.03
−0.06
−0.07
−0.08
−0.19
−0.1
−0.6
−0.29
−0.26
OPM %
—
—
—
—
—
—
—
—
—
—
—
−580%
−520%
Other Income
0.02
0
−0.01
−0.02
−0.02
0.01
0.01
0
0.02
0
0.53
0.02
0.02
Interest
0
0
0
0
0
0
0
0
0
0
0.11
0.16
0.16
Depreciation
0
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0
0
0
0
PBT
−0.02
−0.04
−0.05
−0.06
−0.06
−0.06
−0.07
−0.09
−0.18
−0.1
−0.18
−0.43
−0.4
Tax %
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
—
Net Profit
−0.02
−0.04
−0.05
−0.06
−0.05
−0.06
−0.07
−0.08
−0.17
−0.1
−0.18
−0.43
−0.4
EPS (₹)
−0.05
−0.09
−0.12
−0.14
−0.12
−0.14
−0.16
−0.19
−0.4
−0.23
−0.42
−1.01
−0.93
Div. Payout %
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
—

Balance Sheet

₹ Cr
531207 balance sheet, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
4.27
4.27
4.27
4.27
4.27
4.27
4.27
4.27
4.27
4.27
4.27
4.27
Reserves
−6
−6.04
−6.09
−6.15
−6.2
−6.26
−6.33
−6.41
−6.58
−6.68
−6.86
−7.29
Borrowings
2
1.99
2.03
2.04
2.05
2.07
2.21
0.05
0
2.43
2.37
2.81
Other Liabilities
0.04
0.06
0.07
0.11
0.14
0.18
0.1
2.33
2.47
0.13
0.25
0.22
Total Liabilities
0.31
0.28
0.28
0.27
0.26
0.26
0.25
0.24
0.16
0.15
0.03
0.01
Fixed Assets
0.2
0.19
0.19
0.18
0.17
0.17
0.16
0.16
0.15
0.15
0
0
CWIP
0
0
0
0
0
0
0
0
0
0
0
0
Investments
0
0
0
0
0
0
0
0
0
0
0
0
Other Assets
0.11
0.09
0.09
0.09
0.09
0.09
0.09
0.08
0.01
0
0.03
0.01
Total Assets
0.31
0.28
0.28
0.27
0.26
0.26
0.25
0.24
0.16
0.15
0.03
0.01

Cash Flow

₹ Cr
531207 cash flow, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
−0.03
0.01
0
0
0
0
0
−2.21
−0.16
−0.06
−0.47
−0.27
Investing
0
0
0
0
0
0
0
2.21
0.16
0.06
0.59
0.44
Financing
0.03
−0.01
0
0
0
0
0
0
0
0
−0.11
−0.16
Net Cash Flow
0
0
0
0
0
0
0
0
0
0
0
0.01
Free Cash Flow
−0.03
0.01
0
0
0
0
0
−2.21
−0.16
−0.06
0.18
−0.27
CFO/OP
75
−33
0
0
0
0
0
2,762
84
60
78
93

Ratios

531207 financial ratios, annual
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
—
—
—
—
—
—
—
—
—
—
—
0
Inventory Days
—
—
—
—
—
—
—
—
—
—
—
0
Cash Conversion Cycle
—
—
—
—
—
—
—
—
—
—
—
0
Working Capital Days
—
—
—
—
—
—
—
—
—
—
—
−1,606
ROCE %
−7.84%
−8.16%
−13.95%
−16.22%
−21.43%
−60%
−60.87%
—
—
—
—
—

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Cresanto Global insights

55 extracted metrics across FY11–FY27.

Shareholding Pattern

As of Sep 2026

  • Public 44.09%
  • Promoters 32.27%
  • Others 22.68%
  • DIIs 0.96%

No promoter shares pledged as of 14 Oct 2026

Change vs previous quarter

Not shown for some quarters: Others. Not available separately for this quarter: the shareholding filing gives Public and Others as one figure, shown under Public, so Others is left blank rather than estimated.

Documents

Frequently Asked Questions about Cresanto Global

What does Cresanto Global Limited do?
Incorporated in 1994, Cresanto Global Ltd is in the business of flexible packaging and trading business.
Where is Cresanto Global Limited (CRESANTO) listed?
Cresanto Global Limited trades under code 531207 on the BSE.
Which sector does Cresanto Global Limited belong to?
Cresanto Global Limited is classified under the Healthcare sector, in the Pharmaceuticals industry.

Company Information

Incorporated in 1994, Cresanto Global Ltd is in the business of flexible packaging and trading business.

Website raymedlabs.com
Listed 19 Jul 2011
Face Value ₹10

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/531207.md for Cresanto Global Limited: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Pharma stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month